SCHAFFHAUSEN, CH / ACCESSWIRE / May 3, 2023 / Occlutech Holding AG Occlutech Holding AG (Occlutech) is a leading specialist provider of minimally invasive structural heart implants. The company sells and markets its products in around 85 countries and the global addressable market for congenital and structural heart devices provides a […]
Tag: Occlutech
Occlutech Receives Subscription Commitment of Bonds Amounting to EUR 40 million in Nominal Value Under a Total Frame of EUR 75 million to Finance US Expansion and Growth
SCHAFFHAUSEN, CH / ACCESSWIRE / April 5, 2023 / Occlutech Holding AG Occlutech Holding AG (“Occlutech”), one of the world’s leading providers of minimally invasive structural heart disease devices, receives subscription commitment subject to certain conditions, of bonds to an aggregated amount of EUR 40 million. Bonds amounting to EUR 20 […]
Occlutech Announces First Patient Enrollment in Important US Pivotal Study for the Atrial Flow Regulator (FROST-HF)
SCHAFFHAUSEN, CH / ACCESSWIRE / March 13, 2023 / Occlutech Holding AG (“Occlutech”), one of the world’s leading providers of minimally invasive structural heart disease devices, continues its progress in the US market. Today, the company has announced that the first patient has been enrolled in the FROST-HF study. The FROST-HF […]
Occlutech Announces Change to the Executive Management Team
SCHAFFHAUSEN, SWITZERLAND / ACCESSWIRE / February 1, 2023 / Occlutech Holding AG Occlutech Holding AG (“Occlutech”), one of the world’s leading providers of minimally invasive structural heart disease devices, appoints Dr. Morwan Choli as the new Vice President of Regulatory Affairs & Quality (VP RA&Q). Morwan Choli will be part of […]
Occlutech Continues its Progress in US FDA Study OCCLUFLEX – Enrolls First Patient in Europe
SCHAFFHAUSEN, CH / ACCESSWIRE / January 31, 2023 / Occlutech Holding AG Occlutech Holding AG (“Occlutech”), one of the world’s leading providers of minimally invasive structural heart disease devices, continues its progress in the US market. The first patient has now been enrolled in the global US study OCCLUFLEX in […]
Occlutech Announces New Member to the Executive Management Team by Appointing Chief Medical Officer
SCHAFFHAUSEN, SWITZERLAND / ACCESSWIRE / November 1, 2022 / Occlutech Holding AG Occlutech Holding AG (“Occlutech”), one of the world’s leading providers of minimally invasive structural heart disease devices, has appointed Jozef Bartunek, MD, PhD, as new Chief Medical Officer (CMO), thus expanding its Executive Management Team. Jozef Bartunek is a […]
Occlutech Announces New Members to the Executive Management Team – Appoints Chief Commercial Officer and Vice President Global Business Development & Marketing
SCHAFFHAUSEN, SWITZERLAND / ACCESSWIRE / September 6, 2022 / Occlutech Holding AG Occlutech Holding AG (“Occlutech”), one of the world’s leading providers of minimally invasive structural heart disease devices has expanded its Executive Management Team by appointing two new members. Jose de la Cortina has been recruited as Chief Commercial Officer […]
Occlutech Q2 2022 – Positive Revenue Growth and Important Milestones Achieved in the Strategic US Market
SCHAFFHAUSEN, CH / ACCESSWIRE / August 24, 2022 / Occlutech Holding AG Occlutech Holding AG (Occlutech) is a leading specialist provider of minimally invasive structural heart implants. The company sells and markets its products in around 85 countries and the global addressable market for congenital and structural heart devices provides a […]
Occlutech Q1 2022 – Strong Revenue Increase and Important Milestones Achieved in the Strategic US Market
SCHAFFHAUSEN, SWITZERLAND / ACCESSWIRE / May 31, 2022 / Occlutech Holding AG Occlutech Holding AG (Occlutech) is a leading specialist provider of minimally invasive structural heart implants. The company sells and markets its products in around 85 countries and the global addressable market for congenital and structural heart devices provides a […]
Occlutech Announces Changes to the Executive Management Team
SCHAFFHAUSEN, SWITZERLAND / ACCESSWIRE / May 31, 2022 / Occlutech Holding AG Occlutech Holding AG (Occlutech), a leading specialist provider in minimally invasive structural heart implants has changed its Executive Management Team with three new members. Thomas Okke Frahm has been recruited as VP IT while Sakarias Lindell and Luis Martin-Parras, […]
Recent
Investor Insights with Greg Garfield of KCK: Greg’s journey into investing at their operational experience
Barnes-Jewish Hospital, Biome Analytics Collaborate to Deliver Improved Clinical Outcomes for Cardiovascular Patients
Positron Corporation Secures Agreement for Three NeuSight PET-CT 64 Slice Scanners
Popular
- No commented posts yet